JP Morgan Chase’s MiMedx Group MDXG Stock Holding History

JP Morgan Chase’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-112,500	Closed	-$695K	–	5822
2018 Q3	$695K	Sell	112,500 -10,000	-8%	-$45.2K	﹤0.01%	4118
2018 Q2	$783K	Buy	122,500 +32,500	+36%	+$231K	﹤0.01%	3955
2018 Q1	$627K	Buy	90,000 +27,000	+43%	+$314K	﹤0.01%	3914
2017 Q4	$794K	Buy	+63,000	New	+$768K	﹤0.01%	3851
2017 Q2	–	Sell	-152,300	Closed	-$1.45M	–	5106
2017 Q1	$1.45M	Buy	152,300 +141,900	+1,364%	+$1.2M	﹤0.01%	3223
2016 Q4	$92K	Buy	+10,400	New	+$93.4K	﹤0.01%	4420
2015 Q2	–	Sell	-550,000	Closed	-$5.72M	–	4111
2015 Q1	$5.72M	Buy	550,000 +50,000	+10%	+$468K	﹤0.01%	2253
2014 Q4	$5.76M	Buy	+500,000	New	+$4.94M	﹤0.01%	2318

Other funds holding MDXG

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Trigran Investments Northbrook, Illinois $418M AUM 3.34% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

JP Morgan Chase's MDXG Position: Q1 2026 in Review

JP Morgan Chase reduced its MiMedx Group (MDXG) stake by 88% in Q1 2026, selling an estimated $1.72M and leaving 48,778 shares worth $188K. The position accounts for ﹤0.01% of the portfolio, ranked #5502.

JP Morgan Chase first reported a position in MDXG in Q2 2013 and has held it in 41 quarters since. The position peaked at $21M in Q3 2014. 237 funds tracked by Wall St. Rank hold MDXG as of Q1 2026.

JP Morgan Chase held 48,778 shares of MiMedx Group worth $188K as of Q1 2026.
JP Morgan Chase sold 341,677 MiMedx Group shares in Q1 2026, an estimated $1.72M.
MiMedx Group made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #5502 holding.
JP Morgan Chase first reported a position in MiMedx Group in Q2 2013 and has held it in 41 quarters since.
JP Morgan Chase's MiMedx Group position peaked at $21M in Q3 2014.
237 funds tracked by Wall St. Rank held MiMedx Group as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.